Biology of the renal pericyte

Nephrology Dialysis Transplantation

Volumn 27, Issue 6, 2012, Pages 2149-2155

  Smith, Stuart W ^a   Chand, Sourabh ^a   Savage, Caroline O S ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

CD248; Fibrosis; Pericytes; Stroma

Indexed keywords

5' NUCLEOTIDASE; ALPHA SMOOTH MUSCLE ACTIN; DESMIN; ENDOSIALIN; PLATELET DERIVED GROWTH FACTOR BB; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEOCHONDROITIN SULFATE;

ANGIOGENESIS; BASEMENT MEMBRANE; CELL DIFFERENTIATION; CHRONIC KIDNEY DISEASE; ENDOTHELIUM CELL; EPITHELIAL MESENCHYMAL TRANSITION; GLOMERULUS FILTRATION RATE; HUMAN; IMMUNE RESPONSE; KIDNEY FIBROSIS; MESANGIUM CELL; MYOFIBROBLAST; NONHUMAN; PERICYTE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; STROMA CELL; UPREGULATION; VASCULAR SMOOTH MUSCLE;

ANIMALS; HUMANS; KIDNEY; KIDNEY DISEASES; MICROVESSELS; PERICYTES;

EID: 84861919237     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs134     Document Type: Review

References (80)

1. Lin SL, Chang FC, Schrimpf C et al. Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis. Am J Pathol 2011; 178: 911-923
2. Kida Y, Duffield JS. Frontiers in research: chronic kidney diseases: the pivotal role of pericytes in kidney fibrosis. Clin Exp Pharmacol Physiol 2011; 38: 1440-1681
3. Schrimpf C, Duffield JS. Mechanisms of fibrosis: the role of the pericyte. Curr Opin Nephrol Hypertens 2011; 20: 297-305
4. Duffield JS, Humphreys BD. Origin of new cells in the adult kidney: results from genetic labeling techniques. Kidney Int 2011; 79: 494-501
5. Humphreys BD, Lin SL, Kobayashi A et al. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol 2010; 176: 85-97
6. Lin SL, Kisseleva T, Brenner DA et al. Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. Am J Pathol 2008; 173: 1617-1627
7. Mayer G. Capillary rarefaction, hypoxia, VEGF and angiogenesis in chronic renal disease. Nephrol Dial Transplant 2011; 26: 1132-1137
8. Bohle A, Mackensen-Haen S, Wehrmann M. Significance of postglomerular capillaries in the pathogenesis of chronic renal failure. Kidney Blood Press Res 1996; 19: 191-195
9. Crisan M, Yap S, Casteilla L et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008; 3: 301-313
10. Dore-Duffy P, Cleary K. Morphology and properties of pericytes. Methods Mol Biol 2011; 686: 49-68
11. Rouget C. Mémoire sur le développement, la structure et les propriétés physiologiques des capillaires sanguins et lymphatiques. Arch Physiol Norm Pathol 1873; 5: 603-663
12. Zimmerman K. Der feinere Bau der Blutcapillaren. Z Anat Entwicklungsgeschite 1923; 68: 29-36
13. Meyrick B, Reid L. The effect of continued hypoxia on rat pulmonary arterial circulation. An ultrastructural study. Lab Invest 1978; 38: 188-200
14. Courtoy PJ, Boyles J. Fibronectin in the microvasculature: localization in the pericyte-endothelial interstitium. J Ultrastruct Res 1983; 83: 258-273
15. Hughes CC. Endothelial-stromal interactions in angiogenesis. Curr Opin Hematol 2008; 15: 204-209
16. Diaz-Flores L, Gutierrez R, Madrid JF et al. Pericytes. Morphofunction, interactions and pathology in a quiescent and activated mesenchymal cell niche. Histol Histopathol 2009; 24: 909-969
17. Armulik A, Abramsson A, Betsholtz C. Endothelial/pericyte interactions. Circ Res 2005; 97: 512-523
18. Shepro D,Morel NM. Pericyte physiology. FASEB J 1993; 7: 1031-1038
19. von Tell D, Armulik A, Betsholtz C. Pericytes and vascular stability. Exp Cell Res 2006; 312: 623-629
20. Smith SW, Eardley KS, Croft AP et al. CD248(1) stromal cells are associated with progressive chronic kidney disease. Kidney Int 2011; 80: 199-207
21. Baluk P, Hashizume H, McDonald DM. Cellular abnormalities of blood vessels as targets in cancer. Curr Opin Genet Dev 2005; 15: 102-111
22. Baluk P, Morikawa S, Haskell A et al. Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumors. Am J Pathol 2003; 163: 1801-1815
23. Simonavicius N, Robertson D, Bax DA et al. Endosialin (CD248) is a marker of tumor-associated pericytes in high-grade glioma. Mod Pathol 2008; 21: 308-315
24. Hellberg C, Ostman A, Heldin CH. PDGF and vessel maturation. Recent Results Cancer Res 2010; 180: 103-114
25. Ozerdem U, Stallcup WB. Early contribution of pericytes to angiogenic sprouting and tube formation. Angiogenesis 2003; 6: 241-249
26. MacFadyen JR, Haworth O, Roberston D et al. Endosialin (TEM1, CD248) is a marker of stromal fibroblasts and is not selectively expressed on tumour endothelium. FEBS Lett 2005; 579: 2569-2575
27. Tomkowicz B, Rybinski K, Foley B et al. Interaction of endosialin/TEM1 with extracellular matrix proteins mediates cell adhesion and migration. Proc Natl Acad Sci USA 2007; 104: 17965-17970
28. Tomkowicz B, Rybinski K, Sebeck D et al. Endosialin/TEM-1/CD248 regulates pericyte proliferation through PDGF receptor signaling. Cancer Biol Ther 2010; 9: 908-915
29. Demoulin JB. No PDGF receptor signal in pericytes without endosialin? Cancer Biol Ther 2010; 9: 916-918
30. MacFadyen J, Savage K, Wienke D et al. Endosialin is expressed on stromal fibroblasts and CNS pericytes in mouse embryos and is downregulated during development. Gene Expr Patterns 2007; 7: 363-369
31. Armulik A, Genove G, Mae M et al. Pericytes regulate the bloodbrain barrier. Nature 2010; 468: 557-561
32. Hardie DL, Baldwin MJ, Naylor A et al. The stromal cell antigen CD248 (endosialin) is expressed on naive CD81 human T cells and regulates proliferation. Immunology 2011; 133: 288-295
33. Cao R, Xue Y, Hedlund EM et al. VEGFR1-mediated pericyte ablation links VEGF and PlGF to cancer-associated retinopathy. Proc Natl Acad Sci USA 2010; 107: 856-861
34. Hirschi KK, D'Amore PA. Pericytes in the microvasculature. Cardiovasc Res 1996; 32: 687-698
35. Adams RH, Alitalo K. Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol 2007; 8: 464-478
36. Carmeliet P. Angiogenesis in health and disease. Nat Med 2003; 9: 653-660
37. Zymek P, Bujak M, Chatila K et al. The role of platelet-derived growth factor signaling in healing myocardial infarcts. J Am Coll Cardiol 2006; 48: 2315-2323
38. Bergers G, Song S. The role of pericytes in blood-vessel formation and maintenance. Neuro Oncol 2005; 7: 452-464
39. Saunders WB, Bohnsack BL, Faske JB et al. Coregulation of vascular tube stabilization by endothelial cell TIMP-2 and pericyte TIMP-3. J Cell Biol 2006; 175: 179-191
40. Lindblom P, Gerhardt H, Liebner S et al. Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall. Genes Dev 2003; 17: 835-1840
41. Hellstrom M, Gerhardt H, Kalen M et al. Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. J Cell Biol 2001; 153: 543-553
42. Hellstrom M, Kalen M, Lindahl P et al. Role of PDGF-B and PDGFRbeta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 1999; 126: 3047-3055
43. Morisada T, Kubota Y, Urano T et al. Angiopoietins and angiopoietin-like proteins in angiogenesis. Endothelium 2006; 13: 71-79
44. Fukushi J, Makagiansar IT, Stallcup WB. NG2 proteoglycan promotes endothelial cell motility and angiogenesis via engagement of galectin-3 and alpha3beta1 integrin. Mol Biol Cell 2004; 15: 3580-3590
45. Guillemin GJ, Brew BJ. Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification. J Leukoc Biol 2004; 75: 388-397
46. Crisan M, Huard J, Zheng B et al. Purification and culture of human blood vessel-associated progenitor cells. Curr Protoc Stem Cell Biol 2008; Chapter 2: Unit 2B 2 1-2B 2 13
47. Crisan M, Deasy B, GavinaMet al. Purification and long-term culture of multipotent progenitor cells affiliated with the walls of human blood vessels: myoendothelial cells and pericytes. Methods Cell Biol 2008; 86: 295-309
48. Bagley RG, Weber W, Rouleau C et al. Human mesenchymal stem cells from bone marrow express tumor endothelial and stromal markers. Int J Oncol 2009; 34: 619-627
49. Salvucci O, Maric D, Economopoulou M et al. EphrinB reverse signaling contributes to endothelial and mural cell assembly into vascular structures. Blood 2009; 114: 1707-1716
50. Gerhardt H, Semb H. Pericytes: gatekeepers in tumour cell metastasis? J Mol Med (Berl) 2008; 86: 135-144
51. Schlondorff D. The glomerular mesangial cell: an expanding role for a specialized pericyte. FASEB J 1987; 1: 272-281
52. Yamanaka N. Development of the glomerular mesangium. Pediatr Nephrol 1988; 2: 85-91
53. Levéen P, Pekny M, Gebre-Medhin S et al. Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes Dev 1994; 8: 1875-1887
54. Lindahl P, Hellstrom M, Kalen M et al. Paracrine PDGF-B/PDGFRbeta signaling controls mesangial cell development in kidney glomeruli. Development 1998; 125: 3313-3322
55. Schlondorff DO. Overview of factors contributing to the pathophysiology of progressive renal disease. Kidney Int 2008; 74: 860-866
56. Stockand JD, Sansom SC. Glomerular mesangial cells: electrophysiology and regulation of contraction. Physiol Rev 1998; 78: 723-744
57. Watanabe S, Yoshimura A, Inui K et al. Acquisition of the monocyte/macrophage phenotype in human mesangial cells. J Lab Clin Med 2001; 138: 193-199
58. Song B, Niclis JC, Alikhan MA et al. Generation of induced pluripotent stem cells from human kidney mesangial cells. J Am Soc Nephrol 2011; 22: 1213-1220
59. Kaissling B, Le Hir M. The renal cortical interstitium: morphological and functional aspects. Histochem Cell Biol 2008; 130: 247-262
60. Pallone TL, Silldorff EP. Pericyte regulation of renal medullary blood flow. Exp Nephrol 2001; 9: 165-170
61. Crawford C, Kennedy-Lydon TM, Callaghan H et al. Extracellular nucleotides affect pericyte-mediated regulation of rat in situ vasa recta diameter. Acta Physiol (Oxf) 2011; 202: 241-251
62. Hallan SI, Ritz E, Lydersen S et al. Combining GFR and albuminuria to classify CKD improves prediction of ESRD. J Am Soc Nephrol 2009; 20: 1069-1077
63. Hewitson TD. Renal tubulointerstitial fibrosis: common but never simple. Am J Physiol Renal Physiol 2009; 296: F1239-F1244
64. Strutz F. How many different roads may a cell walk down in order to become a fibroblast? J Am Soc Nephrol 2008; 19: 2246-2248
65. Wada T, Sakai N, Matsushima K et al. Fibrocytes: a new insight into kidney fibrosis. Kidney Int 2007; 72: 269-273
66. Pinzani M. Hepatic stellate (ITO) cells: expanding roles for a liverspecific pericyte. J Hepatol 1995; 22: 700-706
67. Blomhoff R, Wake K. Perisinusoidal stellate cells of the liver: important roles in retinol metabolism and fibrosis. FASEB J 1991; 5: 271-277
68. Ponticos M, Abraham D, Alexakis C et al. Col1a2 enhancer regulates collagen activity during development and in adult tissue repair. Matrix Biol 2004; 22: 619-628
69. Bou-Gharios G, Garrett LA, Rossert J et al. A potent far-upstream enhancer in the mouse pro alpha 2(I) collagen gene regulates expression of reporter genes in transgenic mice. J Cell Biol 1996; 134: 1333-1344
70. Yata Y, Scanga A, Gillan A et al. DNase I-hypersensitive sites enhance alpha1(I) collagen gene expression in hepatic stellate cells. Hepatology 2003; 37: 267-276
71. Faulkner JL, Szcykalski LM, Springer F et al. Origin of interstitial fibroblasts in an accelerated model of angiotensin II-induced renal fibrosis. Am J Pathol 2005; 167: 1193-1205
72. Li L, Zepeda-Orozco D, Black R et al. Autophagy is a component of epithelial cell fate in obstructive uropathy. Am J Pathol 2010; 176: 1767-1778
73. Koesters R, Kaissling B, Lehir M et al. Tubular overexpression of transforming growth factor-beta1 induces autophagy and fibrosis but not mesenchymal transition of renal epithelial cells. Am J Pathol 2010; 177: 632-643
74. Zeisberg M, Duffield JS. Resolved: EMT produces fibroblasts in the kidney. J Am Soc Nephrol 2010; 21: 1247-1253
75. Kriz W, Kaissling B, Le Hir M. Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy? J Clin Invest 2011; 121: 468-474
76. Quaggin SE, Kapus A. Scar wars: mapping the fate of epithelialmesenchymal-myofibroblast transition. Kidney Int 2011; 80: 41-50
77. Jeansson M, Gawlik A, Anderson G et al. Angiopoietin-1 is essential in mouse vasculature during development and in response to injury. J Clin Invest 2011; 121: 2278-2289
78. Ozerdem U, Stallcup WB. Pathological angiogenesis is reduced by targeting pericytes via the NG2 proteoglycan. Angiogenesis 2004; 7: 269-276
79. Floege J, Eitner F, Alpers CE. A new look at platelet-derived growth factor in renal disease. J Am Soc Nephrol 2008; 19: 12-23
80. Chen YT, Chang FC, Wu CF et al. Platelet-derived growth factor receptor signaling activates pericyte-myofibroblast transition in obstructive and post-ischemic kidney fibrosis. Kidney Int 2011; 80: 1170-1181